THRIVE IMAGE GENERATOR
DEAD

Serial Number

90738795

Owner

Thrive Bioscience, Inc.

Attorney

Jeanne Hamburg

Filing Date

May 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

THRIVE IMAGE GENERATOR Trademark

Serial Number: 90738795

THRIVE IMAGE GENERATOR is a trademark filed by Thrive Bioscience, Inc. on May 27, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Thrive Bioscience, Inc. (20 trademarks)

11 Audubon Road
Wakefield, MA 01880

Entity Type: 03

Trademark Details

Filing Date

May 27, 2021

Registration Date

Not Registered

Published for Opposition

September 20, 2022

Goods & Services

Apparatus and instruments for collecting and analyzing data on cells, including but not limited to individual cells, colonies of cells, stem cells, tissues, combinations of cells, co-cultures, namely cell cultures containing two or more different types of cells, organoids, namely, tiny, self-organized three-dimensional tissue cultures that are derived from stem cells, spheroids, namely, three-dimensional cell cultures that arrange themselves during proliferation into sphere-like formations, assembloids, namely, three dimensional structures formed from the fusion and functional integration of multiple cell types and embryos, for laboratory and research, namely, incubators for cell cultures, microscopes for cell imaging, cameras for cell imaging, computers for cell analysis, cell counting apparatus, cell culture media for cell sorting and bioreactors for cell feeding, laboratory pipettes for cell passaging, cell culture media for cell plating, and computers for cell evaluation; pharmaceutical apparatus and instruments, namely, electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; diagnostic apparatus for the detection of pathogens, genetic mutations, diseases or infections for laboratory and research use; downloadable computer software for collecting and analyzing data on cells for laboratory, research, clinical, diagnostic or medical use, for cell imaging, cell counting, cell sorting, cell evaluation, detection of pathogens, genetic mutations, diseases or infections, monitoring of cell response to drugs and pathogens, measuring and evaluating cell response and resistance to drugs and pathogens, where cells, include but are not limited to individual cells, colonies of cells, stem cells, tissues, combinations of cells, co-cultures, namely cell cultures containing two or more different types of cells, organoids, namely, tiny, self-organized three-dimensional tissue cultures that are derived from stem cells, spheroids, namely, three-dimensional cell cultures that arrange themselves during proliferation into sphere-like formations, assembloids, namely, three dimensional structures formed from the fusion and functional integration of multiple cell types

Apparatus and instruments for collecting and analyzing data on cells, including but not limited to individual cells, colonies of cells, stem cells, tissues, combinations of cells, co-cultures, namely cell cultures containing two or more different types of cells, organoids, namely, tiny, self-organized three-dimensional tissue cultures that are derived from stem cells, spheroids, namely, three-dimensional cell cultures that arrange themselves during proliferation into sphere-like formations, assembloids, namely, three dimensional structures formed from the fusion and functional integration of multiple cell types and embryos, for medical use, namely, incubators for cell cultures, cameras, microscopes, flow cytometers and flow-based analyzers providing cell analysis, detection, counting, cell imaging, cell culture media for cell sorting and dropping pipettes for cell passaging, cell culture media for cell plating, and computers for cell evaluation; medical apparatus for introducing pharmaceutical preparations into the human body; clinical medical diagnostic instruments for the analysis of body fluids; diagnostic apparatus for the detection of pathogens, genetic mutations, diseases or infections for medical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2024 EXRA
SOU EXTENSION 4 GRANTED
Oct 16, 2024 EX4G
SOU EXTENSION 4 FILED
Oct 16, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 16, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 19, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2024 EXRA
SOU EXTENSION 3 GRANTED
Feb 12, 2024 EX3G
SOU EXTENSION 3 FILED
Feb 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
Oct 31, 2023 EX2G
SOU EXTENSION 2 FILED
Oct 31, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 31, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 27, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 16, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 9, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2021 NWOS
NEW APPLICATION ENTERED
May 31, 2021 NWAP